Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
Top Cited Papers
Open Access
- 14 May 2009
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 113 (20), 4992-5001
- https://doi.org/10.1182/blood-2008-09-178046
Abstract
We evaluated 26 901 patients who underwent allogeneic hematopoietic cell transplantation (HCT) at 271 centers worldwide to define patterns of posttransplantatioKeywords
This publication has 42 references indexed in Scilit:
- Umbilical cord blood transplantation: Basic biology and clinical challenges to immune reconstitutionClinical Immunology, 2008
- EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCTBone Marrow Transplantation, 2008
- T cell–depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulinBlood, 2007
- Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reactionScandinavian Journal of Infectious Diseases, 2007
- Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplantBone Marrow Transplantation, 2004
- High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatmentBone Marrow Transplantation, 2003
- B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcomeBone Marrow Transplantation, 1999
- Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experienceBone Marrow Transplantation, 1998
- Statistical Methods in Cancer Research, Vol. II: The Design and Analysis of Cohort Studies.Published by JSTOR ,1990
- Secondary Cancers after Bone Marrow Transplantation for Leukemia or Aplastic AnemiaNew England Journal of Medicine, 1989